GLYNN CAPITAL MANAGEMENT LLC - Merck & Co Inc ownership

Merck & Co Inc's ticker is MRK and the CUSIP is 589331107. A total of 27 filers reported holding Merck & Co Inc in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
GLYNN CAPITAL MANAGEMENT LLC ownership history of Merck & Co Inc
ValueSharesWeighting
Q1 2019$1,919,000
+8.8%
23,0680.0%0.36%
-5.8%
Q4 2018$1,763,000
+7.8%
23,0680.0%0.38%
+14.6%
Q3 2018$1,636,000
+16.9%
23,0680.0%0.33%
+8.9%
Q2 2018$1,400,000
+11.4%
23,0680.0%0.30%
+7.5%
Q1 2018$1,257,000
-3.2%
23,0680.0%0.28%
+0.7%
Q4 2017$1,298,000
-12.1%
23,0680.0%0.28%
-24.8%
Q3 2017$1,477,000
-0.1%
23,0680.0%0.37%
-6.8%
Q2 2017$1,478,000
+0.8%
23,0680.0%0.40%
-10.4%
Q1 2017$1,466,000
+8.0%
23,0680.0%0.44%
-4.1%
Q4 2016$1,358,000
-5.7%
23,0680.0%0.46%
+1.8%
Q3 2016$1,440,000
+8.4%
23,0680.0%0.46%
+5.1%
Q2 2016$1,329,000
+8.8%
23,0680.0%0.43%
+9.1%
Q1 2016$1,221,000
+0.2%
23,0680.0%0.40%
+4.2%
Q4 2015$1,218,000
+6.9%
23,0680.0%0.38%
+1.3%
Q3 2015$1,139,000
-13.3%
23,0680.0%0.38%
-10.0%
Q2 2015$1,313,000
-1.0%
23,0680.0%0.42%
-17.6%
Q1 2015$1,326,000
+1.2%
23,0680.0%0.51%
+9.7%
Q4 2014$1,310,000
-4.2%
23,0680.0%0.46%
-2.9%
Q3 2014$1,367,000
+2.5%
23,0680.0%0.48%
+10.4%
Q2 2014$1,334,000
+1.8%
23,0680.0%0.43%
-16.3%
Q1 2014$1,310,000
+13.4%
23,0680.0%0.52%
+27.5%
Q4 2013$1,155,000
+5.2%
23,0680.0%0.40%
+11.6%
Q3 2013$1,098,000
+2.4%
23,0680.0%0.36%
-16.0%
Q2 2013$1,072,00023,0680.43%
Other shareholders
Merck & Co Inc shareholders Q2 2018
NameSharesValueWeighting ↓
KAHN BROTHERS GROUP INC 952,741$56,087,898,0009.47%
Bruce & Co., Inc. 259,400$15,270,0003.99%
LAU ASSOCIATES LLC 56,252$3,312,0003.35%
BENNICAS & ASSOCIATES, INC. 56,308$3,315,0003.00%
BONTEMPO OHLY CAPITAL MGMT LLC 60,360$3,553,0002.90%
Mengis Capital Management, Inc. 45,436$2,674,0002.13%
MARSHWINDS ADVISORY CO 67,712$3,986,0001.90%
Grassi Investment Management 127,444$7,503,0001.36%
Sterling Investment Advisors, Ltd. 27,474$1,617,0001.29%
Westbourne Investment Advisors, Inc. 21,345$1,257,0001.10%
View complete list of Merck & Co Inc shareholders